Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
基本信息
- 批准号:8724574
- 负责人:
- 金额:$ 41.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAgonistAnti-Inflammatory AgentsAnti-inflammatoryBrainCell DeathCell LineCellsCessation of lifeChronicCytokine SignalingDiseaseDopaminergic CellDoseFunctional disorderGenesHumanIL-13Ralpha1Immune systemIn VitroInflammationInjection of therapeutic agentInterleukin-13Interleukin-4InterleukinsKnockout MiceLigandsLipopolysaccharidesMediatingMediator of activation proteinMicrogliaModelingMolecularMusNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressParkinson DiseasePathogenesisPeripheralPlayPredispositionReactive Oxygen SpeciesReporterRoleSignal PathwaySignal TransductionSignaling MoleculeSourceStressSubstantia nigra structureSystemTestingToxic effectTransgenic MiceTyrosine 3-MonooxygenaseX Chromosomebasecytokinedopaminergic neuronhuman IL13RA1 proteinin vivointerleukin-13 receptormaleneuroinflammationneuron lossneurotoxicnew therapeutic targetnovelpars compactapublic health relevancereceptorresearch study
项目摘要
DESCRIPTION (provided by applicant): We hypothesize that the anti-inflammatory cytokines IL-13 and IL-4 play an important role in the death of dopaminergic neurons in the Substantia nigra pars compacta (SNc), the same cells that are lost in human Parkinson's disease (PD). This hypothesis is based on our preliminary studies in mice which showed that interleukin 13 receptor alpha 1 chain (IL-13Ralpha1), is highly expressed in DA neurons in the SNc and that mice that are deficient is this receptor are protected from the loss of dopaminergic (DA) neurons that occurs during chronic peripheral injection with low doses of LPS. Furthermore, in vitro studies using a dopaminergic cell line showed that while IL-13 alone does not have harmful effects on DA neurons, it strongly potentiates the toxicity of mild oxidative stress. Similar resuls were obtained with IL-4, another cytokine capable of activating IL- 13Ralpha1-dependent signaling. Together these results suggest a novel mechanism whereby anti-inflammatory cytokines can contribute to neuronal loss under conditions of stress. We propose to investigate our hypothesis in three specific aims. In SA1, we will determine how the interaction between IL-13 (and IL-4) signaling and oxidative stress induces neuronal damage in vitro. In SA2, we will investigate the contribution of each of these cytokines to neuronal loss in vivo in a model of neuro-inflammation. In SA3, we will determine the cellular source of IL-13 and IL-4 during inflammation. These studies are highly relevant to understanding the role of inflammation in the pathogenesis of PD and may identify novel therapeutic targets for the treatment of this disease.
描述(由申请人提供):我们假设抗炎细胞因子IL-13和IL-4在尼格拉PARS Compacta(SNC)的多巴胺能神经元死亡中起重要作用,该细胞在人类帕金森氏病(PD)中丢失的细胞(同一细胞)。该假设基于我们在小鼠中的初步研究,该研究表明,介体13受体α1链(IL-13RALPHA1)在SNC的DA神经元中高度表达,并且缺陷的小鼠是该受体受到该受体免受多巴胺疗(DA)神经元丧失的神经元的保护,而多巴胺疗(DA)神经元在慢性peripection peripecection peripecection low persection low persection in low persection low posecection low posecection。此外,使用多巴胺能细胞系的体外研究表明,虽然仅IL-13对DA神经元没有有害影响,但它强烈增强了轻度氧化应激的毒性。用IL-4获得了类似的RESUL,这是另一种能够激活IL-13ralpha1依赖信号传导的细胞因子。这些结果共同提出了一种新的机制,在这种机制中,抗炎细胞因子可以在压力条件下导致神经元丧失。我们建议在三个特定目标中研究我们的假设。在SA1中,我们将确定IL-13(和IL-4)信号传导与氧化应激之间的相互作用如何在体外诱导神经元损伤。在SA2中,我们将研究这些细胞因子对神经炎症模型中每种细胞因子对体内神经元丧失的贡献。在SA3中,我们将在炎症过程中确定IL-13和IL-4的细胞来源。这些研究与了解炎症在PD发病机理中的作用高度相关,并且可以鉴定出治疗该疾病的新型治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUNO CONTI其他文献
BRUNO CONTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUNO CONTI', 18)}}的其他基金
Calorie Restriction, Body Temperature and Alzheimers Disease
热量限制、体温和阿尔茨海默病
- 批准号:
10727319 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
- 批准号:
10542643 - 财政年份:2022
- 资助金额:
$ 41.35万 - 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
- 批准号:
10190052 - 财政年份:2021
- 资助金额:
$ 41.35万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
8612661 - 财政年份:2013
- 资助金额:
$ 41.35万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
9066821 - 财政年份:2013
- 资助金额:
$ 41.35万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
9313963 - 财政年份:2013
- 资助金额:
$ 41.35万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
8846153 - 财政年份:2013
- 资助金额:
$ 41.35万 - 项目类别:
Brain interleukin-18 control of food intake and energy expenditure
脑白细胞介素 18 控制食物摄入和能量消耗
- 批准号:
8373865 - 财政年份:2012
- 资助金额:
$ 41.35万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting visceral pain through intestinal neuropod cell GUCY2C signaling
通过肠道神经足细胞 GUCY2C 信号传导治疗内脏疼痛
- 批准号:
10837293 - 财政年份:2023
- 资助金额:
$ 41.35万 - 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
- 批准号:
10705750 - 财政年份:2022
- 资助金额:
$ 41.35万 - 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
- 批准号:
10527744 - 财政年份:2022
- 资助金额:
$ 41.35万 - 项目类别:
Traumatic brain injury and aging: targeting the cholinergic system for deficits in sustained attention and executive function
创伤性脑损伤和衰老:针对胆碱能系统的持续注意力和执行功能缺陷
- 批准号:
10847725 - 财政年份:2020
- 资助金额:
$ 41.35万 - 项目类别:
Traumatic brain injury and aging: targeting the cholinergic system for deficits in sustained attention and executive function
创伤性脑损伤和衰老:针对胆碱能系统的持续注意力和执行功能缺陷
- 批准号:
10618173 - 财政年份:2020
- 资助金额:
$ 41.35万 - 项目类别: